Statements from Andrew Makaka, (the Director of Health , Financing in the Ministry of Health who is also in charge of Mutuelle de Santé), are in stark contrast with earlier statements that Mutuelle de Santé scheme was performing well financially or in terms of coverage as well as revenue collection.
Why did it take a senatorial committee to uncover issues with the scheme? As a reader, I am skeptical the current team is managing it well, understanding the issues, or able to have a clear way forward.
Reaction to the story, “Lawmakers push for Mutuelle de santé autonomy”, (The New Times, March 25).
What is ailing Mutuelle de Santé scheme?